Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Wilcox

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
British Medical Journal|September 1, 1979
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarctionJ M Roland, R G Wilcox, D C Banks, et al.
Lancet (London, England)|September 3, 1988
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)R G Wilcox, G von der Lippe, C G Olsson, et al.
Lancet (London, England)|May 19, 1990
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early ThrombolysisR G Wilcox, G von der Lippe, C G Olsson, et al.
Journal of the American College of Cardiology|April 1, 1995
Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) studyR C Becker, A Charlesworth, R G Wilcox, et al.
Lancet (London, England)|October 11, 1980
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarctionR G Wilcox, J M Rowley, J R Hampton, et al.
Journal of the American College of Cardiology|May 1, 1996
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)A Langer, S G Goodman, E J Topol, et al.
British Journal of Clinical Pharmacology|June 26, 1999
Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosisN Brown, J A May, R G Wilcox, et al.
Annals of Internal Medicine|December 1, 1996
Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I InvestigatorsP E Aylward, R G Wilcox, J H Horgan, et al.
American Heart Journal|December 2, 2000
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experienceC K Wong, H D White, R G Wilcox, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
British Medical Journal|September 1, 1979
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarctionJ M Roland, R G Wilcox, D C Banks, et al.
Lancet (London, England)|September 3, 1988
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)R G Wilcox, G von der Lippe, C G Olsson, et al.
Lancet (London, England)|May 19, 1990
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early ThrombolysisR G Wilcox, G von der Lippe, C G Olsson, et al.
Journal of the American College of Cardiology|April 1, 1995
Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) studyR C Becker, A Charlesworth, R G Wilcox, et al.
Lancet (London, England)|October 11, 1980
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarctionR G Wilcox, J M Rowley, J R Hampton, et al.
Journal of the American College of Cardiology|May 1, 1996
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)A Langer, S G Goodman, E J Topol, et al.
British Journal of Clinical Pharmacology|June 26, 1999
Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosisN Brown, J A May, R G Wilcox, et al.
Annals of Internal Medicine|December 1, 1996
Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I InvestigatorsP E Aylward, R G Wilcox, J H Horgan, et al.
American Heart Journal|December 2, 2000
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experienceC K Wong, H D White, R G Wilcox, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Pageof 8